Attenuated Technologies

Michael Churchill, Ph.D.

Biotechnology executive, company builder, and scientific founder with experience spanning company formation, precision medicine, translational strategy, clinical development, commercialization, strategic operations, and AI-enabled biotechnology strategy.

A current executive curriculum vitae is available for relevant leadership, company-building, advisory, speaking, and collaboration opportunities.